OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and lack of blinding with biased estimates of intervention effects varies with the nature of the intervention or outcome. DESIGN: Combined analysis of data from three meta-epidemiological studies based on collections of meta-analyses. DATA SOURCES: 146 meta-analyses including 1346 trials examining a wide range of interventions and outcomes. MAIN OUTCOME MEASURES: Ratios of odds ratios quantifying the degree of bias associated with inadequate or unclear allocation concealment, and lack of blinding, for trials with different types of intervention and outcome. A ratio of odds ratios <1 implies that inadequately concealed or non-blinded trials exaggera...
Objectives To study the impact of blinding on estimated treatment effects, and their variation betwe...
Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has...
Research on bias in clinical trials may help identify some of the reasons why investigators sometime...
OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and la...
Objective To examine whether the association of inadequate or unclear allocation concealment and lac...
To synthesise evidence on the average bias and heterogeneity associated with reported methodological...
BACKGROUND: The design of randomised controlled trials (RCTs) should incorporate characteristics (su...
Objective: To synthesise evidence on the average bias and heterogeneity associated with reported met...
Flaws in the design of randomized trials may bias intervention effect estimates and increase between...
Published evidence suggests that aspects of trial design lead to biased intervention effect estimate...
Published evidence suggests that aspects of trial design lead to biased intervention effect estimate...
Objective: To explore whether systematic reviewers selectively include trial effect estimates in met...
BACKGROUND: Randomized trials without reported adequate allocation concealment have been shown to ov...
Objective To quantify and compare the treatment effect and risk of bias of trials reporting biomarke...
Objective: To examine whether exclusions of patients from the analysis of randomized trials are asso...
Objectives To study the impact of blinding on estimated treatment effects, and their variation betwe...
Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has...
Research on bias in clinical trials may help identify some of the reasons why investigators sometime...
OBJECTIVE: To examine whether the association of inadequate or unclear allocation concealment and la...
Objective To examine whether the association of inadequate or unclear allocation concealment and lac...
To synthesise evidence on the average bias and heterogeneity associated with reported methodological...
BACKGROUND: The design of randomised controlled trials (RCTs) should incorporate characteristics (su...
Objective: To synthesise evidence on the average bias and heterogeneity associated with reported met...
Flaws in the design of randomized trials may bias intervention effect estimates and increase between...
Published evidence suggests that aspects of trial design lead to biased intervention effect estimate...
Published evidence suggests that aspects of trial design lead to biased intervention effect estimate...
Objective: To explore whether systematic reviewers selectively include trial effect estimates in met...
BACKGROUND: Randomized trials without reported adequate allocation concealment have been shown to ov...
Objective To quantify and compare the treatment effect and risk of bias of trials reporting biomarke...
Objective: To examine whether exclusions of patients from the analysis of randomized trials are asso...
Objectives To study the impact of blinding on estimated treatment effects, and their variation betwe...
Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has...
Research on bias in clinical trials may help identify some of the reasons why investigators sometime...